MDS Virtual Congress 2021 Archives - Page 106 of 132

SB-0107, a drug repurposing opportunity identified through machine learning, shows the potential to treat Parkinson’s disease motor disability and levodopa-induced dyskinesia in rat and primate models

A. Bordbar, K. Merchant, D. Weiner, M. Hill, J. Brotchie, T. Johnston, I. Famili (San Diego, USA)
Secondary endpoints of a randomized, placebo-Controlled Pilot Study to evaluate the safety of lyophilized PRIM-DJ2727 in Parkinson’s disease

J. Suescun, M. Schiess, Z. Jiang, V. Thyne, T. Iqbal, N. Utay, M. Newmark, A. Dupont, A. Alexander, H. Dupont (Houston, USA)
Self perceived impact of the SARS-COV 2 pandemic on motor, non motor and affective symptoms in Parkinson’s disease and parkinsonisms.

A. Ranghetti, V. Cereda, R. Maestri, C. Siri, M. Canesi (Gravedona Ed Uniti, Italy)
SELF-REHABILITATION WITH CONNECTED INSOLES IN PARKINSON’S DISEASE : RESULTS OF A PILOT STUDY.

A. Laplanche, S. Ferre, D. Jacobs, L. Farid, A. Post, C. Moreau, B. Degos, G. Baille (Paris, France)
Sensory Tricks Modulate Corticocortical and Corticomuscular Connectivity in Cervical Dystonia

S. Cho, S. Lee, H. Shin, M. Hallett (Bethesda, USA)
Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8-years follow-up

A. Sánchez Rodríguez, I. Martínez Rodríguez, M. Sierra, P. Sánchez Juan, I. González Aramburu, M. Rivera Sánchez, J. Andrés Pacheco, A. Gutiérrez-González, O. Cuenca-Vera, J. Madera, A. García-Hernández, J. Infante (Santander, Spain)
Serial olfactory testing for the diagnosis of prodromal Parkinson disease in the Parkinson Associated Risk Syndrome (PARS) study

P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelpiha, USA)
Serum uric acid as a putative biomarker in Prodromal Parkinson’s disease: Longitudinal data from the PPMI study.

C. Koros, A-M. Simitsi, N. Papagiannakis, A. Bougea, A. Prentakis, D. Papadimitriou, I. Pachi, R. Antonelou, E. Angelopoulou, E. Efthymiopoulou, I. Beratis, M. Bozi, S. Papageorgiou, A. Bonakis, M. Stamelou, L. Stefanis (Athens, Greece)
Sex differences in brain and cognition in de novo PD patients

J. Oltra, C. Uribe, A. Campabadal, A. Inguanzo, G. Monté-Rubio, M. Marti, Y. Compta, F. Valldeoriola, C. Junque, B. Segura (Barcelona, Spain)
Sex-Specific APOE ε4 Association with Cognition in Lewy Body Dementia

E. Bayram, S. Scholz, I. Litvan (La Jolla, USA)